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Common variants of HTR3 genes 
are associated with obsessive-
compulsive disorder and its 
phenotypic expression
Hae Won Kim1,2, Jee In Kang1,2, Sang-Hyuk Lee3, Suk Kyoon An1,2, Sung Yun Sohn1,2, 
Eun Hee Hwang2, Su Young Lee4 & Se Joo Kim1,2
Evidence from literature supports the existence of associations between serotonin-related genetic 
variants and obsessive-compulsive disorder (OCD), but few studies have explored the involvement of 
serotonin receptor type 3 genes (HTR3) in OCD. To identify whether HTR3 variability affects an individual’s 
susceptibility to OCD, we examined 10 HTR3 variants in 596 individuals with OCD and 599 controls. A 
significant difference existed in the genotypic distribution of the HTR3B variant rs1176744 between 
individuals with OCD and controls (odds ratio [OR] = 0.74, 95% confidence interval [CI] = 0.60–0.91, 
P = 0.0043). A protective haplotype in HTR3B was also associated with OCD (OR = 0.77, CI = 0.63–0.95, 
permutated P = 0.0179). Analyses of OCD sub-phenotypes demonstrated significant associations 
between rs3758987 and early onset OCD in male subjects (OR = 0.49, CI = 0.31–0.79, P = 0.0031) and 
among rs6766410, rs6443930, and the cleaning dimension in female subjects (OR = 0.36, CI = 0.18–0.69, 
P = 0.0016 and OR = 0.47, CI = 0.29–0.79, P = 0.0030, respectively). Additionally, rs6766410 was related 
to contamination-based disgust in OCD (P = 0.0044). These results support that common HTR3 variants 
are involved in OCD and some of its clinical phenotypes.
Obsessive-compulsive disorder (OCD) is often familial, and findings from twin and family studies have shown 
that obsessive-compulsive symptoms are substantially heritable, with a complex pattern of inheritance1,2. Given 
the evidence in support of a genetic aetiology for OCD, numerous candidate gene association studies have been 
conducted with genetic variants relevant to the pathways for serotonin, dopamine, and glutamate3. Polymorphisms 
related to serotonergic neurotransmission have been the most frequently examined owing to the clinical benefits of 
selective serotonin reuptake inhibitors (SSRIs) in the treatment of OCD. Indeed, a recent meta-analysis suggested 
that variations in two serotonin-related genes, 5-HTTLPR and HTR2A, are associated with OCD3, while clearer 
evidence regarding the effects of other serotonin-related gene variants remains to be found.
Among the several potentially susceptible genes, various studies support the involvement of serotonin receptor 
type 3 (5-HT3) genes (HTR3) in the development of OCD. The 5-HT3 receptor is a Cys-loop ligand-gated cation 
channel that, when activated, mediates rapid depolarizing responses in neurons4. Along with the well-established 
role of these receptors in nausea and emesis, a recent study has suggested that activation of 5-HT3 receptors in the 
posterior insular cortex may enhance conditioned disgust behaviours in rats5. Considering that heightened disgust 
sensitivity appears to contribute to contamination concerns and washing rituals in individuals with OCD6 and in 
non-clinical samples7, 5-HT3 receptors seem to play a pathophysiological role in at least some types of OCD. In 
addition, these receptors reportedly affect cognitive and emotional functions, which may be explained by their 
influence on the release of various neurotransmitters8–10 in brain regions such as the hippocampus, amygdala, stria-
tum, and nucleus accumbens. In line with this preclinical evidence, clinical trials of 5-HT3 antagonists have demon-
strated efficacy in reducing symptoms of OCD11–14. Recently, a randomized, double-blind, placebo-controlled study 
revealed that 5-HT3 antagonists may offer additional clinical benefits when given in combination with SSRIs15.
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To date, five distinct HTR3 genes have been cloned for humans: HTR3A and B are located on chromosome 
11q23.1–216 while HTR3C, D, and E are located on chromosome 3q27.117. A large genome-wide linkage study 
for OCD provided evidence that OCD is linked to markers on chromosome 3q27–28, although the findings did 
not reach the accepted level of statistical significance18. Considering that the markers are 2.5 Mb downstream of 
HTR3C–E, these genes may be positional candidates in OCD. Additionally, several authors have indicated that 
the single nucleotide polymorphism (SNP) rs1062613 in HTR3A is associated with the personality trait of harm 
avoidance19 and the modulation of amygdala activation20 in healthy subjects, both of which are suggested to have 
particular relevance for OCD21. HTR3 genes may therefore be plausible candidates with regard to their involve-
ment in OCD. To the best of our knowledge, however, only two association studies have investigated the involve-
ment of HTR3 in OCD. In a study with 75 trio samples, no significant association was found between the HTR3A 
variant rs1062613 and early onset OCD22,23. The other study utilized case-control samples and demonstrated that 
the HTR3E variant rs7627615 was related to the washing dimension and visual organization scores in OCD24.
Given this paucity of data and the promising clinical outcomes that are being achieved in subjects with OCD 
following the use of 5-HT3 antagonists, we aimed to perform a case-control association study with common 
HTR3 variants in a larger sample of adult OCD probands and controls. Clinical characteristics such as the onset 
age and symptom dimensions were included in the analyses in terms of their relationship to the genetic variants, 
as these phenotypes have been proposed as a means of determining subgroups that are more genetically valid25. 
Furthermore, we sought to establish whether variability in HTR3 contributes to disgust sensitivity, a psychological 
trait closely associated with OCD6. We hypothesized that variations within HTR3 may confer genetic vulnerabil-
ity to OCD and its associated clinical characteristics and psychological traits.
Results
Genotyping quality control. The threshold for the genotyping call rate was set at 95% for each SNP, with 
an average call rate of 99.2%. None of the SNPs in controls, individuals with OCD, or the entire sample signifi-
cantly deviated from the Hardy-Weinberg equilibrium at a Bonferroni-corrected significance level of α = 0.005. 
The minor allele frequencies were > 0.05 for all SNPs. Table 1 provides a detailed description of each SNP.
Subjects. As shown in Table 2, no significant differences were found regarding the sex distribution or years 
of education between the two groups, but individuals with OCD were significantly older than were controls. Of 
the individuals with OCD, 103 (17.3%) were drug-naïve at enrolment. As for the disgust sensitivity trait, both 
groups demonstrated similar scores for core disgust, whereas individuals with OCD scored significantly higher 
on animal reminder disgust and contamination-based disgust.
Single SNP association analysis. Regarding the genotype distributions, four SNPs were nominally signif-
icantly different between individuals with OCD and controls: rs1062613, rs3758987, rs1176744, and rs3782025. 
However, only rs1176744 remained significantly different after Bonferroni correction under an additive model 
(Table 3).
The analyses based on the subjects’ clinical characteristics, including their onset age and symptom dimen-
sions, yielded no significant results for the entire OCD sample. However, significant associations were observed in 
a further analysis stratified by sex. Considering the onset age, the genotype distribution of rs3758987 differed sig-
nificantly between male subjects with early onset OCD and male subjects with late onset OCD under a dominant 
model (Table 4). For the analysis of symptom dimensions, two SNPs, rs6766410 and rs6443930, were significantly 
associated with the cleaning dimension in female subjects under an overdominant model and additive model, 
respectively (Table 5). To determine whether these associations were independent, we performed a conditional 
analysis between these two SNPs. The results of conditional analysis remained significant, which were consistent 
Gene rs number Chr Positiona Genob PHWEc MAF Function
HTR3A rs1062613 11 113846006 99.7 0.2134/0.0959/0.7703 0.112 5′ UTR
HTR3A rs1176713 11 113860425 99.0 0.3753/0.0233/0.0247 0.251 Syn
HTR3B rs3758987 11 113775275 98.3 0.8336/0.7298/1.000 0.250 5′ upstream
HTR3B rs1176744 11 113803028 99.5 0.5108/1.000/0.5639 0.228 Non-Syn
HTR3B rs3782025 11 113807607 97.9 0.0327/1.000/0.1261 0.326 Intron 6
HTR3C rs6766410 3 183774762 99.6 0.6104/0.0502/0.0807 0.404 Non-Syn
HTR3C rs6807362 3 183778010 99.3 0.6738/0.4631/0.8816 0.265 Non-Syn
HTR3D rs6443930 3 183754294 99.6 0.9341/0.6772/0.6814 0.444 Non-Syn
HTR3D rs1000952 3 183755822 99.7 0.2992/0.1587/1.000 0.083 Non-Syn
HTR3E rs7627615 3 183818416 99.7 0.8117/1.000/0.9323 0.218 Non-Syn
Table 1.  Characteristics of the HTR3 variants. Chr, chromosome; HWE, Hardy-Weinberg equilibrium; MAF, 
minor allele frequency; UTR, untranslated region; Syn, synonymous; Non-Syn, non-synonymous. aInformation 
on the chromosomal position is based on NCBI genome build GRCh37.p13. The locations are in reference to 
NM_000869.5 for HTR3A, NM_006028.4 for HTR3B, NM_130770.2 for HTR3C, NM_182537.2 for HTR3D, 
and NM_182589.2 for HTR3E. bGenotyping call rate (%). cP value for Hardy-Weinberg equilibrium among 
controls, individuals with OCD, and the entire sample. Order of P values: control subjects/OCD subjects/total 
subjects.
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with the low linkage disequilibrium (LD) between these SNPs (D′ = 0.05 and r2 = 0). The results of this condi-
tional analysis are provided in Supplementary Table S1.
Concerning the relationship between disgust sensitivity and HTR3 variants in OCD, we found a nomi-
nally significant effect of rs6766410 on the combined disgust scale-revised (DS-R) scores under an overdomi-
nant model (F [3,252] = 3.472, P = 0.0167, Wilk’s λ = 0.960, partial η 2 = 0.040). A follow-up univariate analysis 
of variance revealed that the contamination-based disgust scores were significantly lower in subjects with the 
AC genotype than they were in subjects with the AA/CC genotypes (8.42 ± 3.98 and 9.85 ± 3.98, respectively; 
F [1,254] = 8.251, P = 0.0044, partial η 2 = 0.031). No significant associations were found between the other HTR3 
variants and disgust sensitivity scores in OCD.
Haplotype association analysis. We identified four LD blocks, three of which contained two markers 
from each gene and one of which contained three markers from HTR3C and HTR3E (Supplementary Figure S1). 
For the haplotypes estimated in HTR3B, a significant difference was observed for the distribution of haplotypes 
between individuals with OCD and controls. As shown in Table 6, a specific haplotype C-C was significantly 
associated with a lower risk of being affected by OCD. For the haplotypes in the other HTR3 genes, no evidence 
of a relationship with OCD was found.
Variable OCD (n = 596) Controls (n = 599) P value
Age, years (range) 29.84 ± 10.52 (19–63)
23.44 ± 3.92 
(19–48) < 0.001
Male/Female, n 390/206 393/206 0.950
Education, years 13.56 ± 2.38 13.39 ± 1.95 0.169
Onset age of OCD, years 18.48 ± 8.97
 Early onset (≤ 17years), n (%) 328 (55.0)
 Late onset (> 17years), n (%) 268 (45.0)
 Illness duration, years 11.36 ± 8.30
Basal Y-BOCS score
 Total 24.92 ± 5.94
 Obsessions 12.67 ± 3.03
 Compulsions 12.24 ± 3.43
Basal MADRS score 18.59 ± 8.71
Comorbid diagnosis, n (%)
 Affective disorders 77 (12.9)
 MDD (n = 46)
 Depressive disorder, NOS (n = 21)
 Bipolar I disorder (n = 5)
 Bipolar II disorder (n = 5)
 Anxiety disorders 35 (5.9)
 Panic disorder (n = 22)
 Social phobia (n = 9)
 PTSD (n = 3)
 GAD (n = 1)
 Eating disorders 2 (0.3)
 Tic disorder or Tourette’s disorder 24 (4.0)
 Others 8 (1.3)
Symptom dimensions, present, n (%)
 Symmetry 442 (74.2)
 Forbidden thoughts 506 (84.9)
 Cleaning 437 (73.3)
 Hoarding 201 (33.7)
DS-R score
 Core disgust 29.55 ± 8.08 28.58 ± 7.18 0.108
 Animal reminder disgust 21.63 ± 6.34 18.11 ± 6.52 < 0.001
 Contamination-based disgust 9.12 ± 4.03 7.07 ± 3.44 < 0.001
Table 2.  Sociodemographic and clinical characteristics of the study sample. OCD, obsessive-compulsive 
disorder; Y-BOCS, Yale-Brown obsessive-compulsive scale; MADRS, Montgomery-Åsberg depression rating 
scale; MDD, major depressive disorder; Depressive disorder, NOS, depressive disorder, not otherwise specified; 
PTSD, posttraumatic stress disorder; GAD, generalized anxiety disorder; DS-R, disgust scale-revised.
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Discussion
Here, we explored whether HTR3 genetic variants confer risk for OCD and/or for certain clinical characteristics 
of the disorder. Our results support the involvement of HTR3 in OCD, both in the onset age and in the manifes-
tation of specific symptom dimensions.
We found a global relationship between the HTR3B variant rs1176744 and OCD under an additive model, 
suggesting that the odds of being affected by OCD were reduced by 0.74 times with a one-copy increase of the 
variant C allele. Similarly, the HTR3B haplotype with the C allele was associated with OCD subjects in a protec-
tive manner. These results imply that the variant C allele of rs1176744 may decrease an individual’s susceptibility 
to OCD. On the protein level, this functional Tyr129Ser variant results in slow deactivation and desensitization 
kinetics in variant (p.129S) 5-HT3AB receptors compared to in wild-type ones26. For receptors composed of 
both wild-type (p.Y129) and variant (p.129S) 5-HT3B subunits, an intermediate maximal response to serotonin 
has been demonstrated26; this finding may correlate with our results showing varying degrees of risk for OCD 
according to the variant allele dose. Considering that 5-HT3B subunits are expressed in the hippocampus and 
amygdala27–29, one possible explanation for our result is that alterations in receptor responsiveness might play a 
role in fear conditioning and extinction, which could in turn contribute to OCD susceptibility30. Moreover, it has 
been suggested that the AA genotype of this SNP might increase the risk of developing nausea during paroxetine 
treatment31. As nausea is a common side effect of SSRIs, ascertaining those individuals who are likely to develop 
nausea may facilitate more tailored SSRI treatment strategies. Collectively, the functional variant rs1176744 may 
underlie the genetic aetiology of OCD and could serve as a predictor of an individual’s drug response.
We also found nominally significant associations between OCD and rs1062613, rs3758987, and rs3782025. 
Among these, the odds ratio of rs1062613 was 3.51 under a recessive model, which seems to be a large value for 
a common variant in OCD. Considering that there were only four TT genotypes in controls, our result may have 
been overfitted32. A larger sample of minor allele homozygotes would be needed to obtain a more reliable statistic.
Regarding the onset age of obsessive-compulsive symptoms, we found a significant association between early 
onset OCD and rs3758987 in male subjects. Although this 5′ upstream variant does not directly affect the amino 
SNP
Alleles Genotypes
D/da OCDb Controlb
P 
valuec OCDd Controld
ORdom (95% 
CI); P value
ORrec (95% CI); 
P value
ORovd (95% CI); 
P value
ORadd (95% CI); 
P value
rs1062613 C/T 0.112 0.112 0.9482 474/110/12 467/125/4 1.03 (0.76–1.39); 0.8509
3.51 (1.06–11.63); 
0.0296e
0.94 (0.69–1.27); 
0.6757
1.11 (0.84–1.45); 
0.4736
rs1176713 A/G 0.255 0.247 0.6524 340/204/49 339/211/40 1.03 (0.80–1.32); 0.8087
1.11 (0.69–1.79); 
0.6564e
1.00 (0.77–1.30); 
0.9931
1.04 (0.85–1.26); 
0.7082
rs3758987 T/C 0.233 0.268 0.0481 345/214/30 315/228/43 0.81 (0.63–1.04); 0.0958
0.57 (0.33–0.97); 
0.0365
0.91 (0.71–1.18); 
0.4950
0.80 (0.65–0.98); 
0.0299e
rs1176744 A/C 0.206 0.250 0.0104 376/195/25 337/216/40 0.75 (0.58–0.97); 0.0253
0.46 (0.26–0.82); 
0.0068
0.87 (0.67–1.13); 
0.2998
0.74 (0.60–0.91); 
0.0043e
rs3782025 A/G 0.344 0.308 0.0574 253/265/70 290/226/66 1.41 (1.09–1.81); 0.0078e
1.21 (0.82–1.79); 
0.3276
1.30 (1.01–1.68); 
0.0403
1.25 (1.04–1.51); 
0.0159
rs6766410 A/C 0.403 0.404 0.9667 200/310/85 208/293/94 1.00 (0.77–1.29); 0.9729
0.80 (0.57–1.14); 
0.2161e
1.11 (0.87–1.42); 
0.3970
0.94 (0.78–1.13); 
0.5003
rs6807362 C/G 0.265 0.266 0.9410 318/239/38 321/227/44 1.00 (0.78–1.28); 0.9853
0.79 (0.48–1.30); 
0.3579e
1.07 (0.83–1.37); 
0.6247
0.96 (0.79–1.18); 
0.7222
rs6443930 C/G 0.438 0.451 0.5300 185/298/111 179/297/120 1.05 (0.80–1.38); 0.7164
0.93 (0.68–1.26); 
0.6249
1.10 (0.86–1.40); 
0.4688e
1.00 (0.84–1.19); 
0.9673
rs1000952 A/G 0.078 0.087 0.4132 509/81/6 494/100/2 0.78 (0.56–1.10); 0.1559
3.19 (0.61–16.62); 
0.1410
0.73 (0.51–1.03); 
0.0731e
0.85 (0.62–1.17); 
0.3129
rs7627615 A/G 0.215 0.220 0.7610 366/202/27 364/203/30 0.93 (0.72–1.20); 0.5736
0.83 (0.46–1.51); 
0.5478
0.96 (0.74–1.25); 
0.7536
0.93 (0.75–1.15); 
0.4916e
Table 3.  Distribution of allelic and genotypic frequencies of HTR3 SNPs and their associations with the 
risk of OCD. OCD, obsessive-compulsive disorder; SNP, single nucleotide polymorphism; OR, odds ratio; CI, 
confidence interval; dom, dominant; rec, recessive; ovd, overdominant; add, additive. aLowercase d denotes the 
less frequent allele. bMinor allele frequencies in individuals with OCD and controls. cP values via Pearson’s χ 2  
test for allelic associations. dNumber of genotypes in individuals with OCD and controls. Order of genotypes: 
DD/Dd/dd (d is the minor allele). eGenetic inheritance model with the lowest Akaike information criteria.
Genotype
OCD subjects, total Male subjects Female subjects
Early onset OCD, 
n (%)
OR (95% CI)
P 
value
Early onset OCD, 
n (%)
OR (95% CI)
P 
value
Early onset OCD, 
n (%)
OR (95% CI)
P 
valueNo Yes No Yes No Yes
TT 142 (53.6) 203 (62.7) 1.00 71 (49.3) 156 (65.0) 1.00 71 (58.7) 47 (56.0) 1.00
TC-CC 123 (46.4) 121 (37.3) 0.66 (0.45–0.97) 0.0347 73 (50.7) 84 (35.0) 0.49 (0.31–0.79) 0.0031 50 (41.3) 37 (44.0) 1.18 (0.61–2.29) 0.6281
Table 4.  Association between rs3758987 and the onset age. OCD, obsessive-compulsive disorder; OR, odds 
ratio; CI, confidence interval.
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acid sequence of the encoded protein, this variant may be in LD with a nearby functionally important, but unex-
plored, polymorphism. On the other hand, this SNP might influence regulatory processes related to HTR3B 
expression. As individuals with early onset OCD may represent a genetically more valid subgroup25, further 
research on the physiological relevance of rs3758987, as well as replication of this association in different popu-
lations, is needed.
With regard to the symptom dimensions, the cleaning dimension was significantly associated with two 
non-synonymous SNPs, rs6766410 and rs6443930, in female subjects. When analysing their putative effects with 
PolyPhen-233, we found that neither variant was predicted to be damaging. However, in terms of rs6807362 and 
rs1000952, which were in high LD with rs6766410 and rs6443930, respectively, the analysis revealed that these 
variants were predicted to be possibly or probably damaging (PolyPhen-2 scores [HumDiv] 0.647 and 0.998, 
respectively). Thus, the observed association with rs6766410 and rs6443930 may be attributed to other tightly 
linked functional variants. Notably, rs6766410 was also related to the contamination-based disgust sensitivity. 
Interestingly, the relationships among rs6766410, the cleaning dimension, and disgust sensitivity were the most 
robust under an overdominant model in the same direction, in which the heterozygote genotype AC was signif-
icantly associated with a reduced risk of the cleaning dimension and with lower contamination-based disgust 
scores. These results suggest that molecular heterosis may underlie the relationships among this HTR3C variant, 
the cleaning dimension, and disgust sensitivity. According to Comings and MacMurray34, our results are likely 
related to interaction effects between the wild-type and variant 5-HT3 receptor subunits.
The gender-specific associations found here are consistent with the findings of previous studies, which 
revealed sexually dimorphic effects of the genetic variants on OCD35–37. Although several of our results did not 
reach the experiment-wise significance of α = 0.0017 (0.05/30 ≈ 0.00167) after Bonferroni correction for three 
different strata, the P values obtained from these stratified analyses were the three most significant ones in the 
present study. Interestingly, these associations were consistent with the gender differences observed for OCD 
symptoms, including an earlier onset in men38 and more contamination-related symptoms in women39. The gen-
der differences in clinical manifestations might thus reflect underlying genetic heterogeneity.
Previous studies have shown that 5-HT3 antagonists may be beneficial as OCD treatments11–15. Hence, the 
results of this study may have implications for pharmacogenetic studies utilizing 5-HT3 antagonists in OCD. 
It is plausible that genetic variations and the subsequent alterations in receptor function might elicit different 
responses to 5-HT3 antagonists; clarifications regarding the effects of such genetic variations on an individual’s 
treatment responses may aid in selecting the appropriate treatment options.
To our knowledge, our study on the involvement of HTR3 in OCD analysed the most individuals. Nonetheless, 
our study has several limitations. First is the potential for population stratification. As we did not have infor-
mation on the migration histories of the subjects nor did we include a panel of ancestry-information markers, 
we could not control the potential effects of an undetected population substructure. Although the consider-
able degree of genetic homogeneity among the Korean population40,41 might make bias less likely, the possi-
bility of false-positive associations stemming from population stratification could not be completely excluded. 
Second, as controls were significantly younger than were individuals with OCD, control subjects may develop 
Genotype
OCD subjects, total Male subjects Female subjects
Symptoms, n (%)
OR (95% CI)
P 
value
Symptoms, n (%)
OR (95% CI)
P 
value
Symptoms, n (%)
OR (95% CI)
P 
valueAbsent Present Absent Present Absent Present
rs6766410
 AA-CC 67 (42.4) 218 (49.9) 1.00 51 (49.5) 137 (47.9) 1.00 16 (29.1) 81 (53.6) 1.00
 AC 91 (57.6) 219 (50.1) 0.75 (0.52–1.08) 0.1173 52 (50.5) 149 (52.1)
1.08 
(0.69–1.70) 0.7389 39 (70.9) 70 (46.4)
0.36 
(0.18–0.69) 0.0016
rs6443930
 CC 52 (33.1) 133 (30.4) 42 (40.4) 84 (29.4) 10 (18.9) 49 (32.5)
 CG 68 (43.3) 230 (52.6) 40 (38.5) 146 (51.0) 28 (52.8) 84 (55.6)
 GG 37 (23.6) 74 (16.9) 0.91 (0.70–1.18) 0.4863 22 (21.2) 56 (19.6)
1.21 
(0.88–1.67) 0.2361 15 (28.3) 18 (11.9)
0.47 
(0.29–0.79) 0.0030
Table 5.  Associations between rs6766410 and rs6443930 and the cleaning dimension. OCD, obsessive-
compulsive disorder; OR, odds ratio; CI, confidence interval.
Haplotype (HTR3B)
Hap-score
OCD 
%
Controls 
% OR (95% CI)
Crude P 
value
Permutated 
P valuers3758987 rs1176744
T A 2.39273 73.6 69.1 1.00 (reference)
C C − 2.37972 18.1 22.0 0.77 (0.63–0.95) 0.0173 0.0179
C A 1.17538 4.9 3.8 1.17 (0.79–1.72) 0.2398 0.2410
T C 0.28567 2.2 2.0 1.04 (0.59–1.82) 0.7751 0.7699
Table 6.  Estimated haplotype frequencies in individuals with OCD and controls. OCD, obsessive-
compulsive disorder; OR, odds ratio; CI, confidence interval.
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obsessive-compulsive symptoms later in life. However, this inevitable factor may have exerted only a trivial effect 
on the power, because the lifetime prevalence of OCD is ~1–2% and controls had largely passed the mean age 
of OCD onset42. Third, the DS-R scores were obtained from a subset of subjects, which may have reduced the 
statistical power. Fourth, as the onset age information was collected retrospectively, the potential for recall bias 
cannot be disregarded. Finally, we investigated only 10 of the HTR3 polymorphisms, thus associations with other 
variants may have been missed.
In summary, we found that HTR3 variants influenced the affected status of individuals with OCD and several 
of its phenotypes. These findings support that 5-HT3 receptors are involved in the pathophysiology and clinical 
manifestations of OCD. Future studies focusing on the relationships among these HTR3 variants and the treat-
ment response to 5-HT3 antagonists may elucidate whether genetic variations in the 5-HT3 receptor also influence 
the medication response in individuals with OCD.
Methods
Subjects. The study sample consisted of 596 individuals with OCD and 599 healthy control subjects. 
Unrelated individuals with OCD were consecutively recruited from the outpatient department of psychiatry at 
Severance Hospital, Yonsei University Health System, and diagnosed with the Korean version of the Structured 
Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I 
disorders43 by a trained psychiatrist. Exclusion criteria were as follows: age < 19 or > 65 years, a lifetime history of 
psychotic symptoms, history of substance abuse or dependence in the preceding 6 months, or severe organic or 
neurologic disorders. Subjects with comorbid DSM-IV Axis I disorders were not excluded as long as the obses-
sive-compulsive symptoms were the main reason for seeking treatment. Gender-matched, unrelated controls 
were recruited from the local community through advertisements. Controls with a lifetime history of DSM-IV 
Axis I disorders or neurological disorders were not included in the study. Ethnicity was ascertained through 
self-reports, and only those subjects who identified themselves as ethnically Korean were enrolled.
The onset age of OCD was defined as the age at which the obsessive-compulsive symptoms first occurred, 
as recalled by the subject or family members. The threshold for early onset OCD was considered 17 years of 
age44. The severity of the obsessive-compulsive and depressive symptoms was evaluated with the Yale-Brown 
Obsessive-Compulsive Scale45 and Montgomery-Åsberg Depression Rating Scale46, respectively. The Yale-Brown 
Obsessive-Compulsive Scale symptom checklist was employed to identify the following four previously reported 
symptom dimensions in the meta-analysis47: (1) symmetry–symmetry obsessions and repeating, ordering, and 
counting compulsions; (2) forbidden thoughts–aggressive, sexual, religious, and somatic obsessions and check-
ing compulsions; (3) cleaning–contamination obsessions and cleaning compulsions; and (4) hoarding–hoarding 
obsessions and compulsions. The presence of a dimension was determined based on a lifetime history of one or 
more symptoms in the respective category.
This study was approved by the Institutional Review Board of Severance Hospital. The methods were per-
formed in accordance with the approved guidelines. Written informed consent was obtained from each subject 
at the beginning of the study.
Disgust scale-revised. Information on individual differences in the sensitivity to disgust was obtained 
with the Korean version of the DS-R48 in subsets of the individuals with OCD (n = 256) and controls (n = 478). 
The DS-R is comprised of the following three subscales: core disgust scale, animal reminder disgust scale, and 
contamination-based disgust scale. Core disgust reflects the avoidance or rejection response to disgusting stimuli, 
including bodily waste products, small animals, and rotting foods. Animal reminder disgust indicates the aver-
sion to stimuli that reminds the individual of the animal origins of humans, including body envelope violations 
and death. Finally, contamination-based disgust is associated with the perceived risk of disease contagion6.
SNP selection. We selected 10 SNPs from across all of the HTR3 genes according to either of the following 
criteria: (1) functional variants annotated in dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/) that reside 
within the regulatory region or alter the amino acid sequence of a protein, or (2) variants previously reported to 
be related to OCD or other psychiatric disorders. All selected variants had a verified minor allele frequency > 0.05 
in Asians, as ascertained via the HapMap project database (http://hapmap.ncbi.nlm.nih.gov/; Data Release 28, 
phase II + III August 10, on NCBI B36 assembly, dbSNP b126).
Genotyping. Genomic DNA was prepared from blood samples with the QuickGene-mini80 (FUJIFILM, 
Tokyo, Japan). In a subset of controls (n = 160), DNA was extracted from saliva using the Oragene DNA col-
lection kit (DNA Genotek, Kanata, Ontario, Canada). Genotyping of rs3782025 was performed with the ABI 
PRISM SNaPShot Multiplex kit (ABI, Foster City, CA, USA) according to the manufacturer’s recommendations. 
Analyses were conducted using the GeneMapper software (version 4.0; Applied Biosystems, USA). Genotyping 
of the remaining nine SNPs (rs1062613, rs1176713, rs3758987, rs1176744, rs6766410, rs6807362, rs6443930, 
rs1000952, and rs7627615) was performed with the TaqMan fluorogenic 5′ nuclease assay (ABI, Foster City, CA, 
USA) according to the manufacturer’s instructions. Primer sequences and assay IDs are shown in Supplementary 
Table S2.
Sample power calculation. Statistical power was evaluated under a dominant genetic model using the 
Quanto software (version 1.2.4; http://biostats.usc.edu/software); statistical significance was set at P < 0.05. Given 
the available sample size, the statistical power for detecting a risk allele with an effect size of 1.5 ranged from 0.77 
to 0.88, depending on the minor allele frequency.
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Statistical analysis. Continuous variables are shown as the mean ± the standard deviation. Group dif-
ferences in the demographic data were evaluated with Pearson’s χ 2 tests and independent-samples t-tests for 
categorical variables and continuous variables, respectively. Deviation from Hardy-Weinberg equilibrium was 
tested using an exact test. The strength of the associations between HTR3 SNPs and the risk for OCD and its 
sub-phenotypes (early onset OCD, symmetry, forbidden thoughts, cleaning and hoarding) was examined with 
binominal logistic regression under dominant, recessive, overdominant, and additive models of inheritance. The 
analyses were adjusted for age and sex, and the model with the lowest Akaike information criterion was selected 
as the best-fitting model. The influence of the genetic variants on the disgust sensitivity was evaluated with a 
one-way multivariate analysis of variance and post-hoc univariate analysis of variance, with the genotype as an 
independent variable and the DS-R subscales as dependent variables. Analyses were conducted using the R soft-
ware (version 3.2.1; http://www.r-project.org) and the R package SNPassoc49. The overall statistical significance 
was set at α = 0.005 after Bonferroni correction for the 10 independent SNPs examined. An association was 
regarded as significant for P < 0.005 and nominally significant for 0.005 ≤ P < 0.05.
Haploview software (version 4.2; http://www.broad.mit.edu/mpg/haploview) was used to estimate the pair-
wise LD patterns of the examined SNPs. Haplotype blocks were defined by the solid spine of LD method with 
a D′ threshold of 0.850. Haplotype-based associations were analysed using the R package haplo.stats51, which 
estimates haplotype frequencies with an expectation-maximization algorithm. Haplotype-specific score statistics 
were computed to test for associations between the haplotype distributions and OCD under an additive model 
with the haplo.score function. Odds ratios and 95% confidence intervals were calculated using the haplo.cc func-
tion. A permutation procedure (n = 100,000) was performed in order to estimate the corrected significance of the 
best results.
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